Cargando…

CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease

Parkinson’s disease (PD) and other chronic and debilitating neurodegenerative diseases (NDs) impose a substantial medical, emotional, and financial burden on individuals and society. The origin of PD is unknown due to a complex combination of hereditary and environmental risk factors. However, over...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahman, Mujeeb ur, Bilal, Muhammad, Shah, Junaid Ali, Kaushik, Ajeet, Teissedre, Pierre-Louis, Kujawska, Małgorzata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229276/ https://www.ncbi.nlm.nih.gov/pubmed/35745824 http://dx.doi.org/10.3390/pharmaceutics14061252

Ejemplares similares

Efficient Genome Editing Using CRISPR/Cas9 Technology in Chicory
por: Bernard, Guillaume, et al.
Publicado: (2019)

Neural stem cells for Parkinson’s disease management: Challenges, nanobased support, and prospects
por: Oz, Tuba, et al.
Publicado: (2023)

Bioethical issues in genome editing by CRISPR-Cas9 technology
por: AYANOĞLU, Fatma Betül, et al.
Publicado: (2020)

Exploring nano-enabled CRISPR-Cas-powered strategies for efficient diagnostics and treatment of infectious diseases
por: Dubey, Ankit Kumar, et al.
Publicado: (2022)

Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
por: Burgio, Gaetan
Publicado: (2018)

Edition of TFAM gene by CRISPR/Cas9 technology in bovine model
por: de Oliveira, Vanessa Cristina, et al.
Publicado: (2019)

Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme
por: Al-Sammarraie, Nadia, et al.
Publicado: (2021)

Correction to: Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
por: Burgio, Gaetan
Publicado: (2018)

CRISPR/Cas9 genome editing technology in filamentous fungi: progress and perspective
por: Song, Runjie, et al.
Publicado: (2019)

Optimized protocol for gene editing in adipocytes using CRISPR-Cas9 technology
por: Qiu, Yan, et al.
Publicado: (2021)

Review of applications of CRISPR-Cas9 gene-editing technology in cancer research
por: Zhao, Ziyi, et al.
Publicado: (2021)

Application progress of CRISPR/Cas9 genome-editing technology in edible fungi
por: Zhang, Yan, et al.
Publicado: (2023)

FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling
por: Arias-Fuenzalida, Jonathan, et al.
Publicado: (2017)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)

Using Graphene-Based Biosensors to Detect Dopamine for Efficient Parkinson’s Disease Diagnostics
por: Kujawska, Małgorzata, et al.
Publicado: (2021)

CRISPR/Cas9 or prime editing? – It depends on…
por: Schenke, Dirk
Publicado: (2020)

Harnessing CRISPR-Cas system diversity for gene editing technologies
por: McKay, Alexander, et al.
Publicado: (2021)

Targeted genome and epigenome editing using engineered TALE and CRISPR/Cas9 technologies
por: Gersbach, Charles A
Publicado: (2014)

A glance at the application of CRISPR/Cas9 gene-editing technology in cardiovascular diseases
por: Roshanravan, Neda, et al.
Publicado: (2022)

CRISPR/Cas9 Genome-Editing Technology and Potential Clinical Application in Gastric Cancer
por: Almeida, Renata Sanches, et al.
Publicado: (2022)

Exploring magneto-electric nanoparticles (MENPs): a platform for implanted deep brain stimulation
por: Kujawska, Małgorzata, et al.
Publicado: (2022)

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021)

Inducible in vivo genome editing with CRISPR/Cas9
por: Dow, Lukas E, et al.
Publicado: (2015)

Efficient Mitochondrial Genome Editing by CRISPR/Cas9
por: Jo, Areum, et al.
Publicado: (2015)

CRISPR/Cas9: Transcending the Reality of Genome Editing
por: Chira, Sergiu, et al.
Publicado: (2017)

Genome Editing in Cotton with the CRISPR/Cas9 System
por: Gao, Wei, et al.
Publicado: (2017)

CRISPR/Cas9 Editing for Gaucher Disease Modelling
por: Pavan, Eleonora, et al.
Publicado: (2020)

Spatiotemporal control of CRISPR/Cas9 gene editing
por: Zhuo, Chenya, et al.
Publicado: (2021)

Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
por: Duan, Li, et al.
Publicado: (2021)

CRISPR–Cas9 Based Bacteriophage Genome Editing
por: Zhang, Xueli, et al.
Publicado: (2022)

CRISPR/Cas9 genome editing for neurodegenerative diseases
por: Nouri Nojadeh, Jafar, et al.
Publicado: (2023)

CRISPR-Cas9 gene editing and human diseases
por: Jinka, Chaitra, et al.
Publicado: (2022)

CRISPR/Cas9 Essential Gene Editing in Drosophila
por: Osadchiy, I. S., et al.
Publicado: (2023)

CRISPR/Cas9 gene editing: A new hope for transthyretin amyloidosis treatment
por: Shahzad, Faizan, et al.
Publicado: (2022)

Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma
por: Yu, Shijing, et al.
Publicado: (2023)

CRISPR/Cas9 Edited sRAGE-MSCs Protect Neuronal Death in Parkinson’s Disease Model
por: Lee, Jaesuk, et al.
Publicado: (2019)

CRISPR-Cas9 Editing in Maize: Systematic Evaluation of Off-target Activity and Its Relevance in Crop Improvement
por: Young, Joshua, et al.
Publicado: (2019)

CRISPR-Cas gene editing technology and its application prospect in medicinal plants
por: Guo, Miaoxian, et al.
Publicado: (2022)

Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections
por: Najafi, Sajad, et al.
Publicado: (2022)

Modern Prometheus: editing the human genome with Crispr-Cas9
por: Kozubek, Jim
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_knb94nlq8gvoemgmii8kce5lbp